Mass-customisation of custom-made medical implants

Projektinformationen

INOVER21

ID Finanzhilfevereinbarung: 768197

DOI 10.3030/768197

Projekt abgeschlossen

EK-Unterschriftsdatum 16 Juni 2017

Startdatum 1 Juli 2017

Enddatum 31 Dezember 2019

Finanziert unter

• SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies

Gesamtkosten € 2 267 398,75

EU-Beitrag € 1 587 179,13

Koordiniert durch

UAB ORTHO BALTIC
Lithuania

Ziel

Custom-Made Implants (CMIs) are considered to be a superior solution for the treatment of patients with rare and severe clinical conditions since they ensure better fit, lower surgical invasiveness, shorter surgery time, faster healing, reduce risks of infection, joint dislocation and revision surgeries leading to lower total pathology treatment costs. Also, they provide fuller restoration of patient’s physical performance and higher quality of life by reducing or avoiding side effects. Thus, CMIs provide added value for all - patients, surgeons, medical institutions and health insurance funds. However, CMIs currently fail to achieve large-scale commercial success due to high price, long lead times and dominated surgical approach oriented towards standard solutions. Currently CMIs in value account for only ~1.4% of implant market.
Ortho Baltic has developed the technological infrastructure for CMIs design, manufacturing and validation. It consist of surgeon-manufacturer co-creation and communication tool MICE (Medical Implants Customization Engine) and factory floor management system MC Dynamics (Mass Customization Dynamics) that together provide a chance to proceed to mass customization of CMIs. This will lead to the significant decrease of manufacturing costs and lead times. Already today Ortho Baltic offers CMIs for a ~21% lower price than standard modular implants. However, with the successful implementation of the project it could offer CMIs twice cheaper (for an average price of €3260) by 2023 and with lead time < 2 weeks. The profit is expected to be around 1,5 million in 2023. To reach this, during Phase 2 project Ortho Baltic will expand the functionalities of both systems, transfer them to new technology platforms (MICE - to web based platform),pilot them as well as develop supporting tools for CMI application in surgical treatment (clinical decision support and training software MICE Trainer and international curriculum for medical students and surgeons).

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › surgery
• medical and health sciences › health sciences
• medical and health sciences › basic medicine › pathology
• medical and health sciences › medical biotechnology › implants
• natural sciences › computer and information sciences › databases › relational databases

Programm/Programme

• H2020-EU.3.6. - SOCIETAL CHALLENGES - Europe In A Changing World - Inclusive, Innovative And Reflective Societies Main Programme
• H2020-EU.2.3.1. - Mainstreaming SME support, especially through a dedicated instrument

Thema/Themen

• SMEInst-12-2016-2017 - New business models for inclusive, innovative and reflective societies

Aufforderung zur Vorschlagseinreichung

H2020-SMEInst-2016-2017

Andere Projekte für diesen Aufruf anzeigen

Unterauftrag

H2020-SMEINST-2-2016-2017

Finanzierungsplan

SME-2 - SME instrument phase 2

Koordinator

UAB ORTHO BALTIC

• Netto-EU-Beitrag: € 1 587 179,13
• Adresse: TAIKOS AVE 131 A ; 51124 KAUNAS ; Litauen
• KMU Die Organisation definierte sich zum Zeitpunkt der Unterzeichnung der Finanzhilfevereinbarung selbst als KMU (Kleine und mittlere Unternehmen). Ja:
  Region
  Lietuva › Vidurio ir vakarų Lietuvos regionas › Kauno apskritis
• Region: Lietuva › Vidurio ir vakarų Lietuvos regionas › Kauno apskritis
• Aktivitätstyp: Private for-profit entities (excluding Higher or Secondary Education Establishments)
• Gesamtkosten: € 2 267 398,75